Advanced Search

The American Journal of Psychiatry, VOL. 117, No. 1

CLINICAL NOTES | July 01, 1960

METHOXYPROMAZINE IN CHRONIC SCHIZOPHRENIA

MAX APFELDORF; HANS G. BAUER; THOMAS H. MCGAVACK

Am J Psychiatry 1960;117:72-73.

View Article Information

The VA Center, Martinsburg, W. Va.

Article

text A A A

PDF of the full text article.

Abstract

No appreciable change in adjustment was noted in 12 chronically ill schizophrenics who were subjects of a 6-month double blind study with methoxypromazine. No toxic or untoward side effects were noted with doses ranging from 100 to 600 mg. daily.

Figures in this Article

Your Session has timed out. Please sign back in to continue.

Username

Password

Sign in via Athens (What is this?)

Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.

Forgot Password?

Not a subscriber?

Subscribe Now/Learn More

Purchase Online access to this article for 24 hours

PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.

Submit a Comments

Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

* = Required Field

Comment Author(s)*(if multiple authors, separate names by comma)

Example: John Doe

Affiliation & Institution*

Comment Title*

Comment*

Cancel

Topics

Product Recommendation

CME Activity